XML 48 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Income (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Net sales $ 509,344 $ 499,672
Cost of goods sold 234,055 228,260
Gross profit 275,289 271,412
Selling, general and administrative expense 202,275 185,917
Research and Development Expense 52,543 50,343
Segment profit (loss) 20,471 35,152
Interest expense 3,857 10,977
Foreign exchange losses, net 2,737 1,528
Other (income) expense, net (661) (1,400)
Income before income taxes 14,538 24,047
Provision for income taxes (7,870) (3,875)
Net income including noncontrolling interests 6,668 20,172
Net loss (income) attributable to noncontrolling interests 0 (21)
Net income attributable to Bio-Rad $ 6,668 $ 20,151
Basic earnings per share:    
Net income per share basic attributable to Bio-Rad $ 0.23 $ 0.71
Weighted average common shares - basic 28,791 28,494
Diluted earnings per share:    
Net income per share diluted attributable to Bio-Rad $ 0.23 $ 0.70
Weighted average common shares - diluted 29,059 28,817